Skip to content
ppharmaranks
Menu
Class IIOngoing

Chlorthalidone Tablets recall

FDA recall D-0610-2026 · initiated Jun 5, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jun 24, 2026How we research

Inventia Healthcare Limited recalled Chlorthalidone Tablets in Jun 2026 — an FDA Class II recall (D-0610-2026) because Failed Dissolution Specifications.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Failed Dissolution Specifications

Wrong strength, or it did not keep

The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

[100 tablet bottle] Batch RISA24001; [1000 tablet bottle] Batch RISB24002; Exp. 04/2027

Quantity recalled: 11,460 bottles

Details

Product
Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S. Nationwide.
Initiated
Jun 5, 2026
FDA report date
Jun 24, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Chlorthalidone Tablets recalled?
Inventia Healthcare Limited recalled Chlorthalidone Tablets in Jun 2026 — an FDA Class II recall (D-0610-2026) because Failed Dissolution Specifications. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Chlorthalidone Tablets recalled?
Per the FDA enforcement record, the reason for recall D-0610-2026 was: Failed Dissolution Specifications
Is a recalled Chlorthalidone Tablets dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Chlorthalidone Tablets are affected?
Distributed: U.S. Nationwide.. The recall covers these lots — [100 tablet bottle] Batch RISA24001; [1000 tablet bottle] Batch RISB24002; Exp. 04/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0610-2026.

Source: openFDA Drug Enforcement record D-0610-2026

← All drug recalls